Status:
COMPLETED
MobiChina - A Prospective Multicenter Cohort Study
Lead Sponsor:
AO Innovation Translation Center
Conditions:
Unstable Fracture
Hip Fracture
Eligibility:
All Genders
65+ years
Brief Summary
The study will assess the difference in functionality between early vs. standard mobilization after hip fracture in the Chinese population.
Detailed Description
The primary objective of this prospective observational cohort study is to assess the difference in functionality between Group I and II (see mobilization regimens for the two groups above) at 6 weeks...
Eligibility Criteria
Inclusion
- Age 65 and older
- Diagnosis of an unstable intertrochanteric fractures (AO 31- A2 or A3) treated with an intramedullary nail
- Ability to walk independently or with a walking aid prior to injury
- Informed consent obtained, i.e.: Ability of the patient to understand the content of the patient information / Informed Consent Form and signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved written informed consent
Exclusion
- Severe dementia
- Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
- Prisoner
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Key Trial Info
Start Date :
April 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT02296086
Start Date
April 1 2015
End Date
November 1 2019
Last Update
June 4 2020
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
JiShuiTan Hopsital
Beijing, Beijing Municipality, China
2
3th Hospital of Hebei Medical University of Hebei
Hebei, Hebei, China
3
DCN Hospital
Beijing, China
4
West China Hospital of Sichuan University
Chengdu, China